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S. aureus is a major aetiological agent of ruminant mastitis worldwide. The chronic nature of S. aureus mastitis
makes it difficult to cure and prone to resurgence. In order to identify the bacterial factors involved in this
chronicity, Newbould 305 (N305), a strain that can reproducibly induce mild and chronic mastitis in an
experimental setting, was characterized in depth. We employed genomic and proteomic techniques combined
with phenotype characterization, in order to comprehensively analyse N305. The results were compared with
data obtained on S. aureus RF122, a strain representative of the major clone involved in severe bovine mastitis
worldwide. Five mobile genetic elements were identified in the N305 genome as carrying virulence factors which
correlated with phenotypic features such as cytotoxicity, mammary epithelial cell invasion or host-adaptation. In
particular, the presence and characteristics of surface exposed proteins correlated well with the greater adhesion
and internalization capacities of N305 in bovine mammary epithelial cells. N305 also displayed less diversity of
toxin genes but secreted larger quantities of these toxins, associated with a higher cytotoxicity potential. Our
data are consistent with the invasiveness and host-adaptation features which contribute to the chronicity of S.
aureus mastitis. Mobile genetic elements, exoproteins and surface exposed proteins constitute good targets for
further research to explore the underlying mechanisms related to mastitis chronicity.Introduction
Mastitis is an inflammation of the mammary gland,
which commonly results from a bacterial infection. This
infection first induces local benign symptoms and can
rapidly evolve towards general and severe symptoms and
result in systemic infection. Mastitis dramatically im-
pacts animal health and milk quality, and causes consid-
erable economic losses throughout the global milk
production chain [1]. Staphylococcus aureus is a major
aetiological agent of ruminant mastitis, which is often
difficult to cure and is prone to resurgence and chron-
icity [2]. There is therefore a need to better understand
the mechanisms underlying the chronicity phenomenon* Correspondence: yves.leloir@rennes.inra.fr
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unless otherwise stated.in order to efficiently tackle and prevent S. aureus mas-
titis. Unlike Escherichia coli mastitis, the severity of
which is mainly determined by host factors and not
strain features, the severity of S. aureus mastitis mostly
derives from inter-strain variations in terms of virulence
potential [3,4]. Indeed, some S. aureus strains have re-
portedly induced chronic mastitis associated with mild
symptoms, while others can cause severe mastitis.
Several hypotheses have been put forward to explain
the chronicity of S. aureus mastitis, amongst which cyto-
toxicity, biofilm formation and tissue invasion have been
the most widely investigated. S. aureus strains that se-
crete high levels of Panton-Valentine leukocidin and
alpha toxin are associated with severe but not persistent
mastitis [5-7]. By contrast, low-level cytotoxicity may fa-
cilitate persistence of the infection. Biofilm formation
may also help S. aureus to resist antibiotic therapy and
host defenses. The genetic loci bap and ica, which aretd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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strains that cause less severe but more persistent mas-
titis [8]. Finally, the ability to invade and survive within
mammary epithelial cells may also enable S. aureus to
evade the host immune response and the curative treat-
ments. All the evasive tactics that have been developed by
S. aureus probably influence the rate of cures achieved by
antibiotic therapies, and thus make S. aureus mastitis an
infection difficult to treat.
In contrast with the huge efforts dedicated to the devel-
opment of preventive and treatment strategies against S.
aureus mastitis, little is still known about the genomics of
S. aureus ruminant isolates. Compared to the hundreds of
fully sequenced human isolates, only one bovine strain
(RF122) and one ovine strain (ED133) have been fully se-
quenced, the former in 2007 [9] and the latter in 2010
[10]. We recently completed the set of publicly available
genomic data on ruminant isolates through the sequen-
cing and characterization of two ovine strains [3,11] and
the recent release of three bovine S. aureus S1 [12], M186
[13], Newbould 305 (N305) genomes [14].
N305, a strain isolated in 1958 from a clinical case of
cow mastitis in Orangeville, Ontario, Canada [15] has
been used as a model strain of S. aureus mastitis isolates
during numerous studies relative to vaccine development
[16,17], antibiotic treatments [18], in vitro characterization
[19] or in vivo experiments on bovine [20] and mouse
models [21]. In particular, N305 was shown to reprodu-
cibly induce mild and chronic mastitis in the context of
experimental infections [22,23]. But despite its widespread
use as a prototype strain for chronic infections during aca-
demic and industrial research projects, N305 remains
poorly characterized. A clearer understanding of how a
strain is able to induce chronic mastitis is crucial to find-
ing the Achilles heel in the pathogenicity of S. aureus and
then developing more effective control strategies. In a pre-
vious work, we showed that S. aureus N305 and RF122
displayed different capacities for adhesion and internaliza-
tion in bovine mammary epithelial cells [24]. To gain fur-
ther insight into the characteristics of S. aureus that
correlate with the hypotheses evoked to explain the chron-
icity of mastitis, we have now characterized N305 in depth
at the genome, proteome and phenotype levels, and com-
pared our findings with those obtained on S. aureus
RF122. The results revealed that several features of N305
may contribute to the development of chronic mastitis, in-
cluding mobile genetic elements (MGEs) and the types
and production levels of toxins and surface proteins.Materials and methods
Bacterial strains, growth conditions
Staphylococcus aureus Newbould 305 (hereinafter re-
ferred to as N305) [15] and RF122 [9] were isolated fromcases of bovine mastitis. These strains are well character-
ized and can reproducibly induce severe mastitis (RF122;
[25]; JR. Fitzgerald, University of Edinburgh, personal
communication) or mild mastitis (N305) under experi-
mental conditions [9,15]. N305 was kindly provided by Dr
F. Gilbert (INRA Tours) and received as a lyophilized vial
provided by D.S. Postle (College of Veterinary Medicine,
Cornell University, Ithaca, New York) in 1975 and pre-
pared from the original Newbould 305 isolate supplied by
F.H.S. Newbould. One can therefore consider it is close to
the original isolate (F. Gilbert and P. Rainard, INRATours,
personal communication). Subcultures prior to invasion
assays were performed overnight as follows. S. aureus
strains were grown in brain heart infusion medium (BHI;
Becton Dickinson, Le Pont de Claix, France) at 37 °C
under agitation (180 rpm). The cultures were washed
once with phosphate-buffered saline (PBS) and sus-
pended at different concentrations in Dulbecco’s modi-
fied Eagle’s medium (DMEM; pH 7.4; D. Dutscher,
Brumath, France). Bacterial concentrations in subcul-
tures were estimated by spectrophotometric measure-
ments at 600 nm (OD600). They were further confirmed
using a micromethod, as previously described [26]. The
resulting S. aureus populations (in CFU/mL) were de-
termined on mannitol salt agar (MSA; D. Dutscher,
Brumath, France) after 24 h of incubation at 37 °C.Genome comparison of RF122 and N305
The N305 strain was fully sequenced using the Illumina
technique. The whole genome sequencing and assembly
strategies are described in Bouchard et al. [14]. The
N305 genome sequence was analysed using SurfG + to
predict protein locations (potentially surface exposed
(PSE), secreted, membrane and cytoplasmic proteins)
[27], and PIPS, a software suite designed for the predic-
tion of pathogenicity islands which, in an integrative
manner, utilizes multiple features (such as atypical G + C
content, codon usage deviation, virulence factors, hypo-
thetical proteins, transposases, flanking tRNA and the
absence of this structure in non-pathogenic organisms)
to detect pathogenicity islands [28]. For the PIPS ana-
lysis, the genome sequences of the strains Staphylococ-
cus xylosus C2a (kindly provided by R. Talon and S.
Leroy, INRA Clermont-Ferrand) and Staphylococcus car-
nosus TM300 [29] were used as references. The assign-
ment of protein function to the coding sequences
(CDSs) of the two genomes (N305 and RF122) was per-
formed manually using the results from BLASTP and
the COG (Clusters of Orthologous Groups) [30].
These genome sequences are available at DDBJ/EMBL/
GenBank under the accession numbers AKYW00000000
(N305) and NC_007622 (RF122).
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Biofilm formation
The two S. aureus strains were assayed for biofilm for-
mation using crystal violet staining. The bacteria were
subcultured twice in BHI before adjusting the OD600nm
to 0.004 (corresponding approximately to 106 CFU/mL)
in BHI containing 4 g/L glucose (hereinafter named
BHIglu), in order to promote biofilm formation. Growth
was performed in 96-well microtiter plates with 200 μL
of bacterial suspension per well. BHIglu alone was used
as a negative control. The biofilm staining assays were per-
formed following an incubation period of 24 h at 37 °C.
The microtiter plates were washed twice with phosphate-
buffered saline (PBS), fixed for 20 min at 80 °C and stained
for 10 min with 1% (w/v) crystal violet solution, freshly
diluted 10-fold in distilled water. The plates were then
washed twice with distilled water and allowed to dry at
room temperature. The crystal violet was dissolved in
200 μL of acetic acid solution (33% in distilled water)
for 10 min under gentle agitation. Optical density was
measured at 595 nm using a Spectramax spectrometer.
The S. aureus strain MW2 was used as an internal
normalization standard and biofilm formation by N305
and RF122 was expressed as a ratio ODN305/ODMW2,
and ODRF122/ODMW2.
Cytotoxicity
To assess their cytotoxic effect, the viability of MAC-Tcells
was measured during their incubation with a culture
supernatant at 24 h post-infection using methylthiazolyldi-
phenyltetrazolium bromide (MTT), as previously described
[31]. Briefly, the strains were pre-cultured in RPMI 1640
(Sigma, Saint Quentin Fallavier, France) supplemented with
2.2′dipyridyl (200 mM, Sigma) and then diluted 1000-fold
in fresh RPMI + deferoxamine mesylate (152 mM, Sigma).
These iron-depleted conditions were previously shown to
mimic the mastitis context and to increase the expression
of virulence factors [32]. S. aureus strains were grown
without agitation at 37 °C under microaerophilic condi-
tions, in 50 mL tubes. After 24 h of growth, the cultures
were centrifuged and the supernatants were filtered on
0.22 μm units before being diluted in fresh DMEM at a
ratio of 1:1. The cells were incubated for 24 h in this
medium and then 0.5 mg/mL MTT were added for 4 h at
37 °C in 5% CO2. The medium was removed and isopropa-
nol was added for 30 min under shaking at 350 rpm. Ab-
sorbance was read at 570 nm with a background at
690 nm. Cells treated with PBS diluted in DMEM (ratio
1:1) were used as a negative control (100% viability). Rela-
tive viability was expressed versus PBS-treated cells.
Proteolysis
Proteolysis capacity of S. aureus strains was assessed using
a simple plate assay to visualize milk protein degradation.Briefly, culture supernatants were prepared as described in
cytotoxicity assays, filtered on 0.22 μm units, and concen-
trated 10x in a Speed Vac Concentrator (Savant, Thermo
Scientific). Fifty μL of these supernatants were deposited
in wells in PCA agar medium supplemented with 5% of
skimmed milk. A translucent halo around the wells indi-
cates the casein lysis.
Plasma coagulation
To confirm the presence in N305 of a bovine variant of
von Willebrand binding protein, plasma samples from
cows and goats were prepared from blood collected in
EDTA-coated tubes (blood samples kindly provided by
Jacques Lassalas, UMR1348 PEGASE, INRA Agrocampus
Ouest, Rennes, France). Rabbit plasma (Sigma) was used
as a positive control for coagulase activity. A volume cor-
responding to 108 CFU of N305 or RF122 (overnight cul-
ture on BHI) was pelleted, washed once in PBS and
re-suspended in 300 μL serum. Coagulation was checked
after 4 h of incubation at 37 °C by inverting the tubes.
2-Dimensional gel electrophoresis for the total proteome
and secretome of RF122 and N305
For 2D-PAGE, protein samples were prepared as de-
scribed previously, with some minor changes [3]. Briefly,
S. aureus strains were pre-cultured in RPMI 1640 sup-
plemented with 2.2′-dipyridyl (200 μM) to chelate extra-
cellular iron and consequently reduce intracellular iron
stocks. The cultures were then diluted 1:1000 in fresh
RPMI 1640 with deferoxamine (152 μM). S. aureus
strains were grown without agitation at 37 °C under
microaerophilic conditions, in 500 mL flasks for the
supernatant fraction or in 50 mL tubes for the total frac-
tion and shaving experiments. These conditions were
previously shown to best mimic growth in vivo during
mastitis [32]. The cultures were centrifuged at 7000 g for
10 min and the supernatants were filtered through a
0.22 μm filter unit. Total cell lysate proteins were ob-
tained from bacterial pellets, as previously described
[32].The supernatant proteins were precipitated with 10%
TCA at 4 °C overnight. The samples were centrifuged at
9000 g for 1 h at 4 °C. Protein pellets were washed three
times with 96% ethanol and then dried. Proteins were
solubilized in urea 8 M. The protein concentration was
determined using a Bradford test (Sigma). A constant
amount of proteins was used for each acrylamide gel so
as to enable determination of a relative abundance of a
given protein with respect to the total of secreted pro-
teins. Three biological replicates were used for each
analysis.
To purify the protein extracts, a 2D Clean Up kit (GE
Healthcare, Orsay, France) was used according to the
manufacturer’s instructions, and then the samples were
treated as described previously [3]. Images of the gels
Table 1 General features of Newbould 305 and
comparison to RF122 genome
Newbould 305 RF122
Size (bp) 2 791 699 2 742 531
GC % 32.8 32.8
Number of CDSs 2752 2664
Number of SNPs 48 371
CORE N305 x RF122 2518 (e-value = 1e-5/identity > 70%)
Pseudogenes 6 76
Protein coding genes with COGs 2052 (70.53%) 1903 (70.74%)
rRNA genes 5S rRNA = 7 5S rRNA = 6
16S rRNA = 6 16S rRNA = 5
23S rRNA = 7 23S rRNA = 5
tRNA genes 56 64
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Proteomics consult, Belgium), as previously described
[1,32,33]. Spot volumes were determined and normalized
with regard to the total volume of the gel. After this
normalization, spots with a minimal fold change of 2
and an ANOVA e-value lower than 0.005 were selected
for mass spectrometry analysis. The gel pieces were
processed exactly as described previously [3,34]. A
shaving technique was used to analyse the PSE proteins.
S. aureus cultures were centrifuged at 7000 g for 10 min
and the total cell and supernatant fractions were treated
separately. The pellets were washed twice with PBS. The
bacteria were re-suspended in PBS with sufficient 5 mM
DTT to reach 20 units of OD600nm. Five hundred μL of
this suspension were incubated with 20 μg trypsin for 1 h
at 37 °C under agitation (180 rpm) and then centrifuged
at 10 000 g. The supernatants were filtered through a
0.22 μm filter and incubated overnight with 1 μg trypsin
at 37 °C under agitation. Trypsin digestion was stopped
by adding 15 μL 5% TFA. The controls did not display
any significant loss of viability from the counts of CFUs
before and after shaving.
Identification of proteins
Proteins were identified using NanoLC-ESI-MS/MS as
described by Le Maréchal et al. [1] with some minor
modifications. Peptides were identified using the X! Tan-
dem software. The database used for protein identifica-
tion was composed of predicted proteins based on the
RF122 and N305 genome sequences [9,14], together with
protein data on Staphylococcus aureus (taxon 1280) in
the UniProtKB database [35], in order to obtain a statis-
tically significant identification. To achieve valid identifi-
cation with a high degree of confidence, each protein
must have a minimum of two peptides corresponding to
a p-value lower than 0.05. An auto-validation of peptides
from the X!Tandem search results was performed using
X!TandemPipeline [36]. Prediction of the sub-cellular
localization of proteins was achieved using PSORTb
3.0.2 software [37]. Validated and identified proteins
were then sorted by Clusters of Orthologous Groups
(COGs) using EggNOG 3.0 software [38].
Regarding proteins identified by trypsin shaving, only
those identified with at least two peptides in one strain
and less than two peptides in the other strain were con-
sidered as more abundant in the first strain.
Statistical analysis
All experiments were carried out in triplicates (biological
repeats). The differences in biofilm formation and cyto-
toxicity assays were assessed using paired Student’s t
tests considering a P value lower than 0.05. In proteome
analyses, proteins were considered as over expressed in
total proteome or exoproteome when ANOVA e-valuegiven by SameSpot software was lower than 0.005 and
the minimal fold change was 2.
Results
Comparison of the gene contents of S. aureus RF122 and
Newbould 305
The general features of the N305 genome are summa-
rized in Table 1, which also includes the general features
of RF122 [9]. Predicted proteins were functionally cate-
gorized using the COGs database. The COGs distribu-
tions were similar in the two genomes (see Additional
file 1). The majority of the genes (n = 2518) were com-
mon to both strains. The core genome covers up to 91.5%
and 94.5% of the CDSs of N305 and RF122, respectively.
However, a comparison of the sequences of N305 and
RF122 revealed some differences in their overall genome
content. A total of 48 371 single nucleotide polymorphisms
(SNPs) were found in N305 when compared to RF122.
Among the SNPs located in the CDSs, 10 470 were non-
synonymous and 1690 corresponded to insertions or
deletions. In order to better understand the genomic
features responsible for the phenotypic differences be-
tween N305 and RF122, we further analysed the gene
content of S. aureus N305 in terms of putative MGE,
which appeared to be the principal source of variability
between the two genomes.
Analysis of the N305 genome using the PIPS pipeline
[28] predicted the presence of five putative S. aureus
Pathogenicity Islands (SaPIs). SaPI-N305_1 (contig 1)
contained 35 predicted CDSs markedly similar to the
CDSs of νSaβ already described in RF122 and S. aureus
MW2 (Figure 1A). SaPI-N305_2 (contig 1) contained 15
CDSs markedly similar to a SaPIbov found in strain D30
(isolated in the context of human nasal carriage) [39]
(Figure 1B). SaPI-N305_3 and SaPI-N305_4 were two ad-
jacent putative SaPIs (contig 2) containing 19 and 28
CDSs, respectively. SaPI-N305_3 shared marked similarity
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variant of von Willebrand factor binding protein (vwbSbo5)
(Figure 1C). SaPI-N305_4 shared similarity with SaPIn2,
which was first described in the human S. aureus strain,
N315 [40] (Figure 1D). SaPI-N305_5 (contig 6) contained
35 CDSs, 17 of which were found to be very similar to
SaPI2. PIPS analysis also revealed the presence of two pu-
tative bacteriophages, on contig 5, containing 34 CDSs
and 19 CDSs with homology to Bacteriophage 80alpha
and bacteriophage 187, respectively.
We further analysed the N305 genome while focusing
on genes suspected of being implicated in the chronicity
of infections, i.e. genes reportedly involved in biofilm
formation, cytotoxicity and invasiveness (Table 2). This
revealed differences between the RF122 and N305
strains. Some genes were only found in N305, encoding




Figure 1 Putative SaPIs found in the Newbould 305 genome. Putative
the most closely related SaPI found in public databases. A. Comparison of the p
B. Comparison of the pathogenicity island SaPIN305_2 with SaPIbov found in th
SaPIN305_3 with SaPIbov5 and SaPIbov4. D. Comparison of the pathogenicity is
E. Comparison of the pathogenicity island SaPIN305_5 with SaPI2 found in S. au
orientations. Orange: common genes shared with the most closely related SaPIvariant of the von Willebrand binding protein (vWbSbo5),
fibronectin binding protein B (FnbB), S. aureus surface
protein G (SasG) and 1-acyl-sn-glycerol-3-phosphate
acyltransferase (PlsC). These factors are involved in the
colonization of host tissue (vWbSbo5, FnbB, SasG, and
PlsC) or cytotoxic effects (Hld). A cluster of set genes
(staphylococcal enterotoxins) was also found in SaPI-
N305_4 (Figure 1D and Table 2). None of the strains
possess the bap gene, which encodes a protein impli-
cated in biofilm synthesis in S. aureus. However, they
both have the icaADBC operon and the icaR regulator.
In terms of virulence regulation, the accessory gene
regulator (agr system) of N305 is of type I (while RF122
is agrII), as shown by the genome sequence analysis.
Some genes were only found in RF122, encoding for
leukocidin M (LukM) and Panton-Valentin leukocidin F
(LukF’-PV), toxic shock syndrome toxin 1 (TSST-1),SaPIs of N305 are presented in the upper lines, and compared with
athogenicity island SaPIN305_1 with νSaβ in the RF122 and MW2 strains.
e S. aureus D30 strain [39]. C. Comparison of the pathogenicity island
land SaPIN305_4 with SaPIn2 found in the S. aureus strain N315 [40].
reus RN3984 [41]. Arrows represent open reading frames and their
represented on the Figure; blue: additional or different genes.
Table 2 Presence (+) or absence (-) of virulence-associated genes in RF122 and Newbould 305
Gene name
Biofilm formation Function NB305 RF122
ica operon Biofilm synthesis ica operon + +
bap Biofilm associated protein - -
aap Accumulation-associated protein (associated to biofilm formation) +* -
ypfP, ltaA, ltaS, tag and dlt operons Teichoic and Lipoteichoic acid synthesis + +
cap operon Capsular polysaccharide biosynthesis + +
Secreted toxins Function NB305 RF122
lukE Leukocidin LukE precursor + +
lukD Leukocidin LukD precursor + +
lukM Leukocidin chain lukM precursor - +
lukF’-PV Panton-Valentine leukocidin LukF’-PV chain - +
lukF Leukocidin F subunit + +
lukS leukocidin/hemolysin toxin subunit S + +
hla Alpha-hemolysin precursor + +
hlb Beta-hemolysin precursor + +
hlg (subunits A, B, C) Gamma-hemolysin component + +
hld Delta-hemolysin + -
atl Bifunctional autolysin precursor + +
tst Toxic shock syndrome toxin 1 - +
eta Exfoliative A + +
etb Exfoliative B - +
sea Staphylococcal enterotoxin A + +
sec bov Bovine variant of Staphylococcal enterotoxin C - +
seg Staphylococcal enterotoxin G - +
sei Staphylococcal enterotoxin I - +
sel Staphylococcal enterotoxin L - +
sen Staphylococcal enterotoxin N - +
seo Staphylococcal enterotoxin O - +
Colonisation factors Function NB305 RF122
vwb Secreted von Willebrand factor-binding protein (Wbp) precursor + +
vwbSbo5 SaPI-encoded variant of Wbp carried by SaPIbov5 + -
clfA Clumping factor A + +
clfB Clumping factor B + +
fnbA Fibronectin binding protein A + +
fnbB Fibronectin binding protein B + -
stl Transcriptional Repressor SaPI + +
eap Extracellular adherence protein + +
sasG S. aureus surface protein G + -
plsC 1-acyl-sn-glycerol-3-phosphate acyltransferase + -
sak Staphylokinase - -
spa Immunoglobulin G binding protein A precursor + +
*Newbould 305_2513 possess a CWA domain and is 67% similar to aap gene of S. epidermidis (GeneBank accession number YP_189945).
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L/N/O (SECbov, SEG, SEI, SEL, SEN, SEO). All these
proteins are secreted toxins.
Particular focus on microbial surface components rec-
ognizing adhesive matrix molecule (MSCRAMMs) genes
revealed that their number was higher in N305 than in
RF122. Although both strains carry the gene coding for
fibronectin-binding protein A (fnbA), we found that the
fnbA sequence in N305 had two additional fibronectin-
binding domains when compared to that of RF122
(Figure 2).
The same biofilm formation but broader coagulase
activity spectrum and higher cytotoxic capacities for
N305 during in vitro assays
Based on the differences in gene content revealed by se-
quence analysis, phenotypic differences could be ex-
pected in terms of biofilm formation, coagulase activity,
cytotoxicity and invasive capacities. These four proper-
ties were tested in vitro at the phenotype level (see
Materials and methods for details). In line with the ab-
sence of differences in terms of the content of genes in-
volved in biofilm formation, the two strains did not
display any significant differences in phenotype. Indeed,
RF122 and N305 revealed the same ability to form a bio-
film on an abiotic surface, as determined by Crystal vio-
let staining on a plastic surface (data not shown). By
contrast, with respect to coagulase activity, the presence
of vwbSbo5 (Newbould 305_0962) in the N305 genome
(Figure 1C), whose product was also found in the N305
surface exposed protein (Additional file 2), was clearly
associated with an increased range of coagulase activity.
N305 indeed clotted rabbit, goat and bovine plasma,
whereas RF122 only clotted rabbit plasma (Figure 3A).
Furthermore, N305 displayed greater cytotoxicity on
MAC-T cells than RF122 after co-incubation with their
respective supernatants. The viability of cells incubated
with the N305 supernatant was 89% lower than under
control conditions, whereas the viability of cells incubated
with the RF122 supernatant was 36% lower (Figure 3B).Figure 2 Comparison of the FnbA found in RF122 and N305 with tha
contains 11 Fn-binding sites. FnbA from S. aureus Newbould 305 (A) and RF1
binding regions (FnbRs). High-affinity FnbRs are shaded. Signal peptide (S) in
white; membrane-spanning region (M) in white.N305 supernatant also presented a higher ability to hydro-
lyse caseins as shown by the translucent halo around the
well of N305 deposit (Additional file 3).
Comprehensive analysis of the proteome of S. aureus
Newbould 305
A comprehensive analysis of the N305 proteome (total
cell, surface and secreted proteins) was carried out on
cultures grown under conditions mimicking the context
of mastitis, as described previously [32]. The N305
proteome was compared with that of RF122. A total of
215 proteins were categorized as being differentially pro-
duced in N305 or RF122, and were further identified.
Sixty-eight proteins (31.6%) were identified as being over-
expressed by RF122, and 147 (68.4%) by N305. In more
detail, a total of 33 proteins (15.4% of total proteins) were
identified in the culture supernatant (Additional file 4), 11
proteins being more abundant in RF122 and 22 in N305.
Supernatant gels (Figure 4A and B) displayed the most fla-
grant proteomic differences between N305 and RF122. In
the total cell lysate, 36 proteins (16.7% of total proteins)
were identified (Additional file 5), ten proteins being more
abundant in RF122 and 26 in N305. Trypsin shaving en-
abled the identification of up to 409 proteins because of
the sensitivity of this method, and included 146 proteins
that were relatively more abundant in one strain (67.9% of
total proteins) (Additional file 2), with 47 proteins more
abundant in RF122 and 99 in N305.
The proteins were classified into COGs as a function
of their annotation. Most of the secreted and PSE pro-
teins identified here belonged to cellular processes and
signalling categories or were poorly-characterized pro-
teins. Among these, a number of exoproteases were
found to be common to both strains (Additional files 4
and 2), while some exoproteases such as Spl proteases
(SaPI-N305_1), were also specifically found in N305.
Virulence factors (classified in the category of poorly-
characterized proteins) were also found to be specific to
N305. These included haemolysins and leukotoxins (alpha-
and gamma-haemolysins, LukS/F) and proteins involved int of S. aureus 8325.4. The FnbA in S. aureus 8325.4 (SWISS-Prot P14738)
22 (B) showing the approximate positions of the predicted fibronectin

































Figure 3 Phenotypic characterization of S. aureus N305 and comparison with RF122. A. Coagulase activity of RF122 and N305. A 108 CFU
aliquot was prepared from an overnight culture of each strain, washed and re-suspended in rabbit (cu), bovine (bo) or goat (ca) plasma. After a
4-h incubation at 37 °C, the level of coagulation of observed by tilting the tubes. B. Cytotoxic effects of S. aureus RF122 and N305 supernatants
on MAC-T cells. S. aureus strains were grown for 24 h in RPMI with 50 mM deferoxamine. Supernatants (or PBS for the control condition) were mixed in
DMEM at a ratio of 1:1 and incubated with MAC-T cells. Cytotoxicity was assessed using the MTT test and relative viability was expressed with regard to
PBS-treated cells. Each experiment was performed in triplicate, and differences between the groups were compared using Student’s t test. **P < 0.005.
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http://www.veterinaryresearch.org/content/45/1/106adhesion to host tissues (e.g. Newbould305_1324, encoding
an extracellular matrix and plasma binding protein) and in
evasion of the host immune response (e.g. Spa, vWbpSbo5).
By contrast, RF122 was found to produce leukotoxins (e.g.
LukM/F’ and LukE) and enterotoxins (e.g. bovine variant of
the staphylococcal enterotoxin C sec-bov) as well as iron
metabolism proteins (e.g. IsdB and D). As expected, total
proteins (as well as the surface exposed proteins identified
by trypsin shaving) comprised many more proteins that
those grouped in the Metabolism categories.
Discussion
The outcomes of S. aureus mastitis can vary markedly,
and are mostly linked to strain-dependent features [3].
By contrast with mastitis induced by other pathogens,
one of the most problematic traits of S. aureus mastitis
is its low cure rate and its propensity to chronicity. Here,
we have finely characterized N305 [15], an S. aureus
strain that reproducibly induces mild and chronic mas-
titis in an experimental cow model, and compared it to
RF122, a well-documented and highly virulent S. aureus
strain [25] (J. Ross Fitzgerald, personal communication)
which is representative of a common clone which fre-
quently causes bovine mastitis [9,15]. These two strains
belong to distinct clonal complexes (CC97/ST115 for
N305, and CC133/ST151 for RF122), with both strains
clustering in groups that include several other bovine
strains and strains of human or non-specified origin. Al-
though RF122 has been described as an archetypal bo-
vine strain, it is closely related to human strains. By
contrast, N305 is strongly associated with a bovine host
[42,43].
Despite their phylogenetic divergence, a comparison of
their genome sequences revealed some strong similarities,with a core genome (set of genes common to N305 and
RF122) comprising more than 91% of their gene content
(Table 1). However, certain genomic differences were
found in their pseudogene contents. The RF122 genome
reportedly contains 70 pseudogenes [9], whereas only six
pseudogenes are predicted in the N305 genome. Signifi-
cant differences were also found regarding the genes en-
coding toxins and surface proteins involved in host
invasion. These latter genomic features were confirmed by
phenotypic and proteomic characterizations.
In terms of gene regulation, we found that N305 is
agrI, while RF122 is agrII. The agr system plays a central
role in S. aureus virulence expression. Interestingly, agrI
bovine strains were recently shown associated to persist-
ence, with high intracellular survival and probably a bet-
ter adaptation to an intracellular niche, whereas agrII
was associated with a low intracellular survival and a
probable extracellular niche [44].
An inventory of potential mastitis-associated functions in
N305 reflects host adaptation and propensity to
chronicity
A comparison between the N305 and RF122 genomes
revealed differences regarding the genes encoding PSE
and secreted proteins. The complete spl operon (splA, B,
C, D, E, F; although splC is pseudogenized) was found in
N305 whereas only splB, splC, splE, and splF were found
in the RF122 genome sequence. In addition, a series of four
serine proteases, including SplB (Newbould 305_0049),
SplE, D, and F, encoded by the spl operon, was found to be
relatively more abundant in the N305 supernatant (Table 3).
In agreement, we observed a higher ability of N305 to de-
grade caseins, which is associated to SplA, SplB and SplC
in S. aureus [45,46]. Other differences were found in toxin
Figure 4 2D PAGE of S. aureus RF122 and N305 protein extracts. Supernatants (A and B) and total proteomes (C and D) were harvested
during the stationary phase. Supernatant proteins were precipitated with 10% trichlororacetic acid and washed with high-grade ethanol. Samples
were purified using the 2D Clean Up kit (GE Healthcare) then separated by isoelectrofocalization on pH4-7 strips (total proteome) or pH3-11NL
strips (supernatant) for the first dimension, and by 12% polyacrylamide gels for the second dimension. The gels were stained with Biosafe (Biorad)
Coomassie blue, according to the manufacturer’s instructions. Arrows indicate spots that were over-expressed.
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composition of MGEs. RF122, which is associated with se-
vere mastitis, was found to be well-equipped with genes
encoding enterotoxins, haemolysins, exfoliatin, toxic shock
syndrome toxin, and leukocidin, whereas the N305 gen-
ome carried fewer and different toxin genes. S. aureus
RF122 carried numerous enterotoxin genes, including thebovine-associated variant of staphylococcal enterotoxin C
which is involved in disturbances affecting the immune re-
sponse and is carried by SaPIbov1 [9]. Unlike N305, RF122
was found to possess lukM and lukF’-PV (hereinafter re-
ferred to as lukF’), a lukF-PV variant carried by the pro-
phage φPV83-pro [47]. These genes form LukM/F’ which
is involved in cytotoxicity against polynuclear neutrophils,
Table 3 Compilation of potentially virulence associated proteins identified in this work
Access.c Methodf
Name of the proteina Locus nameb RF122 N305 Massd Loc.e Exo. Tot. Shav.
CELLULAR PROCESSES AND SIGNALING
Cell cycle control, cell division,
chromosome partitioning
Probable transglycosylase IsaA isaA Q2YWD9 J0L078 28.2 S RF122 RF122, N305
Cell wall/membrane/envelope biogenesis
Iron-regulated surface determinant protein A isdA Q2YX95 J0KNZ4 W RF122, N305
Iron-regulated surface determinant protein B isdB Q2YX96 J1ET39 72.0 W RF122 RF122, N305
Iron-regulated surface determinant protein C isdC Q2YX94 J0KVY4 RF122, N305
Iron-regulated protein isdD Q2YX93 J0UGM1 41.2 U RF122
Lipoteichoic acid synthase ltaS Q2YSL2 J1EW90 74.2 C/M RF122
Penicillin-binding protein 2 pbp2 Q2YY56 J1EUU3 80.2 C/M RF122
Post-translational modification, protein
turnover, and chaperones
Serine protease SplE splE Q2YTM5 J1EZ78 25.6 C/M N305
Serine protease SplF splF Q2YTM6 J0KV93 25.6 S N305
Serine protease SplD splD J0L226 25.6 S N305
Serine proteinase (SplB) Newbould 305_0049 Q2YTM3 J0UNB6 27.8 S N305
Chaperone protein DnaK dnaK Q2YT47 J1EZS6 66.2 C RF122 RF122, N305
Alkyl hydroperoxide reductase subunit F ahpF Q2YVH8 J0KUQ5 54.5 C/M RF122 RF122, N305
Alkyl hydroperoxide reductase subunit C ahpC Q2YVK2 J1EYK8 20.9 C RF122 RF122, N305
Trigger factor tig Q2YTB4 J0KVL9 48.4 C N305 RF122, N305
Defense mechanisms
Alkaline shock protein 23 asp23 Q2YYG3 J0KY19 18.6 U N305 RF122, N305
INFORMATION STORAGE AND PROCESSING
Replication, recombination and repair
Thermonuclease nucI Q2YXU2 J0UHM2 21.8 S RF122, N305
Translation, ribosomal structure and biogenesis
Elongation factor Ts tsf Q2YXL1 J0KWZ6 32.3 C N305 RF122 N305
Elongation factor Tu tuf Q2YSB3 J1EVM7 43.0 C N305 RF122, N305
METABOLISM
Carbohydrate transport and metabolism
Glyceraldehyde-3-phosphate dehydrogenase gap Q2YSF2 J0KSH5 36.2 C N305 RF122, N305
Glucose-6-phosphate isomerase pgi Q2YWS3 J0UKP5 49.7 C N305
Enolase eno Q2YSE8 J1EWJ2 47.0 C N305 RF122, N305
Phosphoglycerate kinase pgk Q2YSF1 J1EWC9 42.5 C N305 N305 RF122, N305
Inorganic ion transport and metabolism
Superoxide dismutase M sodM Q2YUU9 J0UM22 22.9 S N305
POORLY CHARACTERIZED
Gamma-hemolysin component A hlgA Q2YVZ2 J0KNX1 36.3 S N305
Gamma-hemolysin component B hlgB Q2YVZ0 J0KVW4 36.6 S RF122, N305
Gamma-hemolysin component C hlgC Q2YVZ1 J1ET20 35.5 S N305
Staphylococcal enterotoxin C-bovine sec-bov Q2YVN9 31.2 S RF122
Superantigen-like protein 7 set5 Q2YVR9 J1EYV6 26.0 S N305
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Table 3 Compilation of potentially virulence associated proteins identified in this work (Continued)
Superantigen-like protein set11 Q2YVM7 J1EYV1 25.7 S N305
Superantigen-like protein set19 J0UMW3 39.8 S N305
Superantigen-like protein Newbould 305_1808 Q2YXF4 J0KPN6 27.7 S N305
Leukocidin F subunit lukA Q2YU84 J1ET76 38.6 S RF122, N305
Leukocidin S subunit lukB Q2YU83 J0KP92 40.2 S N305
Panton-Valentine leukocidin LukF’-PV chain lukF’-PV Q2YWM7 36.4 S RF122
Leukocidin chain lukM lukM Q2YWM8 35.0 S RF122
Leukotoxin E subunit lukE Q2YTQ3 J0L217 34.6 S RF122, N305
Extracellular matrix and plasma binding protein Newbould 305_1324 J0UKH8 38.3 W N305
Uncharacterized protein (vwbSbo5-like) Newbould 305_0962 J0KUT2 57.4 S N305
Immunoglobulin G binding protein A (Protein A) spa J1EXZ6 56.8 W N305
Elastin-binding protein EbpS ebpS Q2YY76 J0KQY7 52.9 C/M RF122, N305
Molecular chaperone Hsp31 and glyoxalase 3 hchA J1EVT7 32.0 C N305
aProteins are classified in COG. Names are given according to annotation of genome sequences
bCorrespond to the commonly found name of the gene.
cAccessions numbers are given according to references on UniProtKB [35].
d Theoretical mass (in kDa) as predicted from the protein sequence [36].
ePredicted localization based on PSORTb software. S = Extracellular C = Cytoplasmic C/M = Cytoplasmic/Membrane W = Cell wall U = Unknown.
fMethod that enabled the observation of the protein with the name of the strain in which the protein was identified: Exo. = Proteins identified in supernatant Tot.
=Proteins identified in total lysate Shav. =Proteins present in trypsin shaving solution.
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the mammary gland. LukM/F’ is more efficient against bo-
vine leukocytes than any other staphylococcal toxin, in-
cluding Panton-Valentine leukocidin [5,48,49]. As for other
leukocidins, both strains contained the lukD/E genes and
lukF/S genes, also described as lukB/A or lukG/H, respect-
ively [50,51], and LukS and LukF subunits were only found
in N305 protein samples (Table 3). However, the LukM/F’
leukotoxin, found in RF122, has a higher affinity for bovine
myeloid lineage cells [5,52] and has been shown to be asso-
ciated with severe clinical mastitis and to be highly preva-
lent in gangrenous mastitis isolates [7,53]. Other toxin
genes are absent from the N305 genome when compared
to that of RF122, which might explain its less virulent
phenotype during mastitis. Genes encoding for toxic shock
syndrome toxin, exfoliatin B and enterotoxins, such as sec
which is carried by SaPIbov, and seg, sei, sen, seo, carried by
an enterotoxin gene cluster (egc), were indeed present in
RF122 and absent from the N305 genome. Enterotoxins
play a major role during staphylococcal infections and can
induce a strong immune response in the mammary gland
[54]. Analysis of the secretomes of RF122 and N305 con-
firmed some of the differences observed in the gene con-
tent, but it also revealed differences in the production of
virulence factors whose genes were present in both ge-
nomes. Hence the production of haemolysins (α- and γ-
haemolysin) was more pronounced in N305, despite the
presence of haemolysin-encoding genes in both strains. In
line with this, N305 displayed a stronger cytotoxic poten-
tial than RF122, as shown by an in vitro MTT assay of
MAC-T cells. However, RF122 has been described as astrain that produces high levels of α-haemolysin [55]. This
discrepancy between the genomic and proteomic profiles
and the expected cytotoxicity phenotype underlines the
importance of the in vivo validation of in silico and prote-
omic analyses. The virulence of S. aureus is obviously asso-
ciated with its gene content, but also with its capacity to
express this genetic equipment in a specific context. The
differences observed here therefore advocated for more se-
vere mastitis with RF122.
Interestingly, SaPI-N305_3, one of the SaPIs predicted
in silico by PIPS analysis, was absent from the RF122
genome and shared homology with the previously de-
scribed SaPIbov4 and SaPIbov5 [56]. This putative SaPI
carries the Newbould 305_0962 gene whose product was
found to be surface-exposed by trypsin shaving in N305.
This gene shares homology with SaPIbov4_ORF15, a
gene encoding a bovine and SaPI-associated variant of
von Willebrand factor binding protein which has been
described in the Staphylococcus aureus strain BA4
pathogenicity island SaPIbov4 [57]. These bovine vari-
ants of vWbp (identified in SaPIbov4 and SaPIbov5)
have been shown to provide carrier S. aureus strains
with an ability to specifically coagulate ruminant plasma,
whereas strains that do not carry these SaPIs (such as
RF122) coagulate rabbit but not ruminant plasma [56].
We were able to show that N305 did indeed clot rumin-
ant (bovine and caprine) plasma. This capacity to coagu-
late plasma is correlated with an ability to induce
abscesses during infections [58]. The formation of ab-
scesses is a mechanism of bacterial resistance against host
immune cells. N305 is therefore endowed with ruminant-
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to the bovine host and correlate with its propensity to in-
duce chronic mastitis.
S. aureus N305 is suitably armed to invade host cells
A genomic comparison of S. aureus N305 and RF122
also revealed differences in colonization and invasion
factors. Most of these factors belong to surface proteins
such as Secretable Expanded Repertoire Adhesive Mole-
cules (SERAMs) or MSCRAMMs, which participate in
both adhesion and the internalization of S. aureus in
host cells [59]. SERAMs or MSCRAMMs interact with
host proteins such as fibronectin, collagen and elastin,
and trigger invasion. Numerous studies have reported
the importance of these factors during an infection. In
particular, fibronectin-binding proteins are considered to
be the principal staphylococcal proteins involved in S.
aureus internalization in host cells [60]. The analysis of
the N305 genome using the SurfG + package [27] en-
abled the identification of PSE proteins. When the gen-
ome comparison of RF122 and N305 was focused on
these PSE proteins, it revealed that N305 is better
equipped than RF122 to achieve host invasion. S. aureus
N305 indeed possesses two fibronectin-binding proteins
(fnbA and fnbB) rather than one for RF122 (fnbA). Fur-
thermore, a comparison of the predicted FnbA protein
sequence revealed that N305 FnbA presented two add-
itional fibronectin-binding domains, and RF122 FnbA
only one. This suggests a greater affinity of N305 for fi-
bronectin. It should be noted that fibronectin-binding
proteins have been shown to be indispensable to the in-
ternalization of S. aureus into host cells [60,61]. Other
surface protein genes were found in N305 while they
were missing from the RF122 genome.
Biofilm formation was not significantly different in the
two strains, in the conditions used (on abiotic surface).
Although bap gene is reportedly associated with chronic
mastitis isolates [8], its absence does not hinder N305 to
induce chronic mastitis. Moreover, the sasG and pls
genes, known to participate in host colonization and
modulate pathogen internalization, were also found in
N305 only. These observations correlate well with previ-
ous studies by our laboratory which compared the adhe-
sion and internalization capacities of both strains,
in vitro, on bovine MEC cultures (MAC-T line). The ad-
hesion and internalization rates of N305 were indeed
significantly higher than those of RF122 [24]. These cap-
acities seem to favour host invasion by S. aureus N305,
and together with the smaller number of toxin genes
and host-adaptation features such as production of the
bovine variant of vWbp, may account for a milder but
chronic phenotype in N305 mastitis.
Some moonlighting proteins were also found in the
proteomic profiles. Proteins identified as being relativelymore abundant in the N305 secretome formed part of
the “Carbohydrate transport and metabolism” COG
category and were also involved in adhesion and
colonization of host tissue, as has been reported for eno-
lase [62,63], glyceraldehyde-3-phosphate deshydrogenase
(GAPDH) [64] and phosphoglycerate kinase (pgk) [65].
Other cytoplasmic proteins reportedly involved in adhe-
sion, such as glucose-6-phosphate isomerase (pgi) [66],
fructose-biphosphate aldolase (fda) [67], superoxide dis-
mutase (sod) [68] and elongation factor Tu (tuf ) [69],
were also found, but in the N305 supernatant only
(Figure 4). The fact that N305 expresses more of these pro-
teins than RF122 may also account for N305′s better cap-
acities to adhere, internalize and cause chronic infections.Conclusions
N305 harbours fewer toxin genes but more colonization
and invasion factors than RF122. In vitro, coagulation,
proteolysis and cytotoxicity were significantly higher in
N305 compared to RF122 as well as adhesion and in-
ternalisation, as previously demonstrated in Bouchard
et al. [24]. This correlated well with its gene content and
proteomic profile. The range of bovine-adaptive features
might account for the propensity of N305 to persistence
and mild and chronic mastitis, which is more difficult to
detect and cure. By contrast, RF122 appeared to be less
well equipped in terms of its genes related to host-
adaptation and tissue invasion, but better equipped in
toxin genes, and therefore more prone to inducing a se-
vere inflammatory response. Whether these two profiles
correspond to the evolutionary strategies of S. aureus
bovine strains towards a commensal or strictly patho-
genic lifestyle is not yet known, and this point deserves
further investigation, including epidemiological studies.
In line with this, based on MLST data, Smith et al. sug-
gested that N305 should be considered as a teat skin asso-
ciated strains [70]. S. aureus N305 nevertheless represents
a strain of choice for further study to improve our under-
standing of the pathogenesis of S. aureus in the context of
chronic mastitis. A complete demonstration of the in-
volvement of the determinants identified here would re-
quire further experiments such as gene disruption and
virulence determination in vivo. The genome sequence
and fine characterization of this strain is a first necessary
step towards developing strategies to understand, prevent
and combat this disease.
Additional files
Additional file 1: CDS classifications of S. aureus Newbould 305 and
RF122 in the biological process. The assignment of protein functions
to the ORFs of the N305 (A) and RF122 (B) genomes was performed manually
using the results from BLASTP and the COG (Clusters of Orthologous Groups).
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Newbould 305.
Additional file 2: Proteins identified with the trypsin shaving
method. This table presents the proteins identified by mass
spectrometry after a trypsin treatment of bacterial surface (see Materials
and methods for details) for RF122 and N305 strains.
Additional file 3: Proteolytic activity of Newbould 305 and RF122
supernatants assessed on PCA agar medium supplemented with 5%
skimmed milk. Proteolysis assays on PCA gelose added with 5% of
skimmed milk. Culture supernatants of S. aureus RF122 (A) and Newbould
305 (B) were concentrated 10x and filtered before depositing 50 μL in a
well. A halo of proteolysis can be observed with N305.
Additional file 4: Proteins identified as differentially abundant in
secretome of S. aureus RF122 and N305. This table presents the
proteins identified by mass spectrometry (see Materials and methods for
details) in the culture supernatants of RF122 and N305 strains.
Additional file 5: Proteins identified as differentially expressed in
the total lysate by S. aureus RF122 and N305. This table presents the
proteins identified by mass spectrometry (see Materials and methods for
details) in the whole cell lysates of RF122 and N305 strains.
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